Cerebrovascular Manifestations of Neurosarcoidosis – An Overview

Neurosarcoidosis (NS) is defined as involvement of either central or peripheral nervous system by non-caseating granulomatous inflammation. They are seen clinically in 5-10% of those with sarcoidosis, though sub-clinical involvement is commoner. Cerebrovascular manifestations of neurosarcoidosis (CVNS) are considered even rarer but availability of novel imaging techniques and awareness of potential imaging markers for NS (yet to be validated), has resulted in better recognition. CVNS can occasionally be the presenting manifestation of sarcoidosis. Despite being rare, those with CVNS may have higher morbidity and mortality compared to other forms of NS. In this review, we aim to describe the clinical features, approach to diagnosis, mimics, investigation and management of CVNS, while attempting to identify features that differentiate central nervous system vasculitis associated with NS (CNSV-NS) from primary central nervous system vasculitis (PCNSV), a close diagnostic mimic.

Authors

Institutions

Publication Details

Journal
Vascular Health and Risk Management
Published
2026-02-01
DOI
https://doi.org/10.2147/vhrm.s505215
Primary Topic
Sarcoidosis and Beryllium Toxicity Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cerebrovascular Manifestations of Neurosarcoidosis – An Overview

Praveen Kesav, Seby John, Anu Jacob, Syed Abou Iltaf Hussain
Vascular Health and Risk Management
Sarcoidosis and Beryllium Toxicity Research
article

Cerebrovascular Manifestations of Neurosarcoidosis – An Overview

Praveen Kesav, Seby John, Anu Jacob, Syed Abou Iltaf Hussain
article en

Abstract

Neurosarcoidosis (NS) is defined as involvement of either central or peripheral nervous system by non-caseating granulomatous inflammation. They are seen clinically in 5-10% of those with sarcoidosis, though sub-clinical involvement is commoner. Cerebrovascular manifestations of neurosarcoidosis (CVNS) are considered even rarer but availability of novel imaging techniques and awareness of potential imaging markers for NS (yet to be validated), has resulted in better recognition. CVNS can occasionally be the presenting manifestation of sarcoidosis. Despite being rare, those with CVNS may have higher morbidity and mortality compared to other forms of NS. In this review, we aim to describe the clinical features, approach to diagnosis, mimics, investigation and management of CVNS, while attempting to identify features that differentiate central nervous system vasculitis associated with NS (CNSV-NS) from primary central nervous system vasculitis (PCNSV), a close diagnostic mimic.

Vascular Health and Risk ManagementVol. Volume 22
Abu Dhabi Health Services (AE)
Good health and well-being
Openalex Percentile: Top 65%
Sarcoidosis and Beryllium Toxicity Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.